THE PATIENT ADVOCATE - Trademark Details
Status: 602 - Abandoned-Failure To Respond Or Late Response
Serial Number
75575837
Word Mark
THE PATIENT ADVOCATE
Status
602 - Abandoned-Failure To Respond Or Late Response
Status Date
2000-03-20
Filing Date
1998-10-23
Mark Drawing
1000 - Typeset: Word(s)/letter(s)/number(s)
Typeset
Attorney Name
Law Office Assigned Location Code
L40
Employee Name
LUTHEY, LYNN A
Statements
Goods and Services
Advertising services, namely, promoting the goods and services of others on a global computer information network
Goods and Services
Providing information in the fields of health and medicine, as well as counseling in the fields of health and medicine, by means of a global computer network
Classification Information
International Class
35 - Advertising; business management; business administration; office functions. - Advertising; business management; business administration; office functions.
US Class Codes
100, 101, 102
Class Status Code
6 - Active
Class Status Date
1998-12-18
Primary Code
035
First Use Anywhere Date
1998-06-01
First Use In Commerce Date
1998-06-01
International Class
42 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
1998-12-18
Primary Code
042
First Use Anywhere Date
1998-06-01
First Use In Commerce Date
1998-06-01
Correspondences
Name
FREDERICK J. MARTIN III
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 1999-06-07 | ASSIGNED TO EXAMINER |
| 1999-06-16 | NON-FINAL ACTION MAILED |
| 2000-03-17 | ASSIGNED TO EXAMINER |
| 2000-03-20 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
